Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-17T19:50:50.498Z.
Calculation as of: 2026-09-17T19:50:50.498Z.
Quote observation: 2026-09-17T19:50:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85eef12130a48b0cf44c76688118bc638692902120f757679f8e8036b24ed865
PEG RATIO
N/A
McKesson Corporation
Market Cap
$103.02B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| McKesson Corporation (MCK) | $103.02B | N/A |
| Sanofi (SNY)vs › | $103.70B | N/A |
| GSK plc (GSK)vs › | $102.07B | N/A |
| Stryker Corporation (SYK)vs › | $107.67B | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $93.25B | N/A |
| CVS Health Corp. (CVS)vs › | $115.07B | N/A |
| Elevance Health Inc. (ELV)vs › | $89.71B | N/A |
| Medtronic plc (MDT)vs › | $119.26B | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.10B | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $127.88B | N/A |
PEG Ratio
N/A
P/E Ratio
23.6
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
